Home » Stocks » MASS

908 Devices, Inc. (MASS)

Stock Price: $64.90 USD 2.45 (3.92%)
Updated Jan 19, 2021 4:00 PM EST - Market closed
After-hours: $64.50 -0.40 (-0.62%) Jan 19, 5:58 PM
Market Cap 1.66B
Revenue (ttm) 29.53M
Net Income (ttm) -3.08M
Shares Out 26.19M
EPS (ttm) -0.12
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 19
Last Price $64.90
Previous Close $62.45
Change ($) 2.45
Change (%) 3.92%
Day's Open 62.22
Day's Range 62.40 - 67.44
Day's Volume 141,563
52-Week Range 49.00 - 67.92

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Business Wire - 4 weeks ago

BOSTON--(BUSINESS WIRE)--908 Devices Inc., a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced the closing of its upsized ...

Seeking Alpha - 4 weeks ago

908 Devices is a very interesting business with great potential and recent operating momentum. Expectations have risen quite a bit after a big opening day move higher; I still like the long-te...

Market Watch - 1 month ago

Shares of 908 Devices Inc. more than doubled on their public debut, as the Massachusetts-based biochemical analysis device company's stock opened 127.6% above the upsized initial public offeri...

Barrons - 1 month ago

Research device maker prices shares at $20 each.

Business Wire - 1 month ago

BOSTON--(BUSINESS WIRE)--908 Devices Inc., a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced the pricing of its upsized ...

Business Wire - 1 month ago

908 Devices, a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced that it has filed a registration statement on Form S-1 wi...

NASDAQ - 1 month ago

908 Devices, which provides a suite of mass spectrometry devices for scientific research, filed on Wednesday with the SEC to raise up to $75 million in an initial public offering.

SEC - 1 month ago

908 Devices, Inc. has filed to go public with an IPO on the NASDAQ.

About MASS

908 Devices develops and sells measurement devices for chemical and biochemical analysis in the United States, China, Japan, Europe, and internationally. The company develops its products using mass spectrometry (Mass Spec) technology, an analytical technique for molecular analysis. It offers handheld and desktop Mass Spec devices for the point-of-need applications in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. Its products include MX908, a handheld, battery-powered, and Mass Spec device that is d... [Read more...]

Industry
Medical Devices
IPO Date
Dec 18, 2020
CEO
Kevin J. Knopp
Employees
96
Stock Exchange
NASDAQ
Ticker Symbol
MASS
Full Company Profile

Financial Performance

In 2019, 908 Devices's revenue was $17.97 million, a decrease of -18.51% compared to the previous year's $22.05 million. Losses were -$13.37 million, 77.5% more than in 2018.

Financial Statements

Analyst Forecasts

According to 4 analysts, the average rating for 908 Devices stock is "Strong Buy." The 12-month stock price forecast is 65.00, which is an increase of 0.15% from the latest price.

Price Target
$65.00
(0.15% upside)
Analyst Consensus: Strong Buy